Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Filaantro presents Raise To Win Press Release
  • From Merchants to Builders: Dawoodi Bohra Expo Opens in Mumbai Amidst the City’s Infrastructure Boom Business
  • Trust, Growth, and Legacy: Tarun Ghulati may soon become the first London Mayor of Indian origin after Rishi Sunak became the first UK Prime Minister with Indian roots Business
  • Veenu Girdhar founder of Zapdill Technologies Associated with IIT Delhi Technology
  • Wroley E – Scooter open for Dealership Business
  • ClassAct 2023 – The Hindustan Times Republic Day Quiz: Top tips from the quizmasters Business
  • IIIA – India International Influencer Awards 2023 Turn Out To Be A Huge Success, Eventz Factory And Kunal Thakkar Praised For The Opulent Show Lifestyle
  • Stray Dog Menace: Government of India Pushes Humane ABC Rules with Funds, Community Role National

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • The Healing Center Homeopathy: Leading the Way in Evidence-Based Homeopathy Across India Health
  • Oxygen Therapy, a vital element for Post Covid Recovery Health
  • GenWorks Advocates For Tackling Cardiovascular Diseases On World Heart Day Health
  • Best and Top Dermatological Care: Celebrating 5 Years of Cozmoderm Clinic’s Journey of Innovation and Excellence Health
  • ASG Eye Hospital and Saumit Group launch awareness campaign for eye care Health
  • Advanced Homeopathy treatment brings New Hope to Aplastic Anemia Patients: Dr. A.K. Dwivedi’s Efforts Shine Health

Recent Posts

  • Jaan Abhi Baaki Hai: A soulful love story that wins hearts Movie Review
  • Sejal Glass Limited Posts Robust FY26 Performance Crossing Rs 400 Cr Total Revenue up 63.85% and Net Profit Surges 163.19%
  • Mitsu Chem Plast Limited Reports Impressive Q4 FY26 Performance; Net Profit Jumps 117.90%, EBITDA Up 72.98%
  • Simca Advertising Limited IPO Opens on May 08, 2026
  • Steel Exchange India Announces Rs 40.32 Crore Capital Strengthening Through Warrant Allotment and Conversion of Existing Warrants

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Role of India in Emerging New World Order Press Release
  • Arnifi, a global setup and management platform announces the launch of its new Management Development Program ‘Arnifi 25 under 25’ Business
  • Delhi Board of School Education and MasterG and Daughters Pvt. Ltd. join Hands to Implement Applied Learning Education in Fashion Studies Education
  • A Birthday Rooted in Service: Abhishek Kumar Tripathi Celebrates with Children and Cows in a Spirit of Devotion Lifestyle
  • PINNACLE Air Bids for retail travel business of Future Retail Business
  • Jindal Mobilitric Unveils EV (Electric Vehicle) With An Impressive 165 Km Range Business
  • Top 10 Most Influential Indian Personalities of the year 2022 announced by Fame Finders Media Business
  • Historic Agnihotra Ceremony Sets Nobel World Record with Participation from 11,111 Households in Dharwad National

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme